Do you want to read an article? Please log in or register.
The use of cellular and molecular biomarkers to manage COPD exacerbations
COPDRespiratory Tract Infection
Related content
RECOMMENDED
COPD
Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Singh D, Wedzicha JA, Siddiqui S, de la Hoz A, Xue W, Magnussen H, Miravitlles M, Chalmers JD, Calverley PMA
doi: 10.1186/s12931-020-01482-1.
RECOMMENDED
COPD
Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J.
Sadatsafavi M, McCormack J, Petkau J, Lynd LD, Lee TY, Sin DD
doi: 10.1183/13993003.02122-2020.
RECOMMENDED
COPD
Clinical and spirometric variables are better predictors of COPD exacerbations than routine blood biomarkers
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Med.
Nuñez A, Marras V, Harlander M, Mekov E, Turel M, Petkov R, Lestan D, Yanev N, Negri S, Barrecheguren M, Pirina P, Miravitlles M, Esquinas C
doi: 10.1016/j.rmed.2020.106091.
RECOMMENDED
COPD
COPD Biomarkers and their Interpretation
Am J Respir Crit Care Med.
Stockley RA, Halpin DMG, Celli BR, Singh D
doi: 10.1164/rccm.201810-1860SO.
COMMENTED
COPD
Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials
Thorax.
Jolliffe DA, Greenberg L, Hooper RL, Mathyssen C, Rafiq R, de Jongh RT, Camargo CA, Griffiths CJ, Janssens W, Martineau AR
doi: 10.1136/thoraxjnl-2018-212092.
RECOMMENDED
COPD
Real-time breath analysis reveals specific metabolic signatures of COPD exacerbations
Gaugg MT, Nussbaumer-Ochsner Y, Bregy L, Engler A, Stebler N, Gaisl T, Bruderer T, Nowak N, Sinues PM, Zenobi R, Kohler M
doi: 10.1016/j.chest.
COPD
Treatment of COPD Exacerbation in Switzerland: Results and Recommendations of the European COPD Audit
Respiration
Buess M, Schilter D, Schneider T, Maurer M, Borer H, Thurnheer R, Köhler E, Junker L, Jahn K, Grob M, Rüdiger J, Geiser T, Helfenstein E, Solèr M, Fiechter R, Sigrist T, Brun P, Barandun J, Koltai E, López-Campos JL, Hartl S, Roberts M, Schumann DM, Tamm M, Stolz D
doi: 10.1159/000477911.
RECOMMENDED
COPD
ERS Statement: A core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J
Mathioudakis AG, Abroug F, Agusti A, Ananth S, Bakke P, Bartziokas K, Beghe B, Bikov A, Bradbury T, Brusselle G, Cadus C, Coleman C, Contoli M, Corlateanu A, Corlateanu O, Criner GJ, Csoma B, Emelyanov A, Faner R, Fernandez Romero G, Hammouda Z, Horváth P, Huerta Garcia A, Jacobs M, Jenkins C, Joos G, Kharevich O, Kostikas K, Lapteva E, Lazar Z, Leuppi JD, Liddle C, Linnell J, López-Giraldo A, McDonald VM, Nielsen R, Papi A, Saraiva I, Sergeeva G, Sioutkou A, Sivapalan P, Stovold E, Wang H, Wen F, Yorke J, Williamson PR, Vestbo J, Jensen JU, DECODE-NET.
doi: 10.1183/13993003.02006-2021
RECOMMENDED
AsthmaCOPD
Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Thorax
David B, Bafadhel M, Koenderman L, De Soyza A
doi: 10.1136/thoraxjnl-2020-215167